EPIPEN NEXTGEN
Live / Applied — Fourth extension granted (statement of use) (as of 19 Nov 2025)
What this means for you
Not registered yet, but its 22 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97851757
- Mark type
- Stylized text
- Filed
- 22 Mar 2023
- Published for opposition
- 03 Oct 2023
Goods and services
- Class 005 — Pharmaceuticals: Injectable pharmaceuticals for treatment of anaphylactic reactions
- Class 010 — Medical apparatus: Medical fluid injectors
Owner
- Mylan Inc., Canonsburg, PA, US
- Mylan Inc., Canonsburg, PA, US
Prior registrations
Prosecution history
- 20 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Nov 2025 — SOU EXTENSION 4 GRANTED
- 19 Nov 2025 — SOU EXTENSION 4 FILED
- 19 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 21 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2025 — SOU EXTENSION 3 GRANTED
- 20 May 2025 — SOU EXTENSION 3 FILED
- 20 May 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2024 — SOU EXTENSION 2 GRANTED
- 18 Nov 2024 — SOU EXTENSION 2 FILED
- 18 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 23 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 May 2024 — SOU EXTENSION 1 GRANTED
- 22 May 2024 — SOU EXTENSION 1 FILED